SoftBank Vision Fund 2 led autistic childcare platform developer Elemy’s latest round, which valued it at $1.15bn.

Prosus Ventures has returned to back an equity and debt round for the homecare management platform developer secured at a $1.25bn valuation.

Helena backed Twin Health, the developer of a metabolic digital twin platform, in a round reportedly valuing it at $740m.

M Ventures has returned to back the cancer therapeutics developer’s $75.5m round, five years after taking part in its series A.

Data collaboration software producer Duality Technologies, e-commerce logistics provider Pandion and cybersecurity software developer Adaptive Shield each raised $30m.

The cancer drug developer has closed an initial public offering which took place alongside a $160m SoftBank-led private placement.

Novartis Venture Fund returned for the small molecule drug developer’s series B round, tipping its total funding to over $100m.

The immuno-oncology drug developer’s prospective initial public offering would mark exits for Takeda, Merck Group, Ipsen and Merck & Co.

The diversified therapeutics developer has filed to go public in the United States a year after Pfizer contributed to its $310m series A round.

Sesame Ventures helped lazy eye treatment developer Luminopia raise $12m while UPS, Qualcomm and Mercado Libre exited courier marketplace Mandaê in a purchase by Nuvemshop.